Spago Nanomedical
0,256
SEK
-4,48 %
SPAGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
-4,48%
+16,36%
+30,61%
+28%
-28,89%
-16,34%
-93,59%
-97,39%
-97,75%
Spago Nanomedical conducts research and development in cancer diagnostics. The company conducts various development projects based on its proprietary nanomaterials whose potential is found in making tumours visible, and enabling internal radiation therapy of cancer. The company was founded in 2007 and is based in Lund.
Læs mereMarkedsværdi
89,14 mio. SEK
Aktieomsætning
12,58 t SEK
Omsætning
1,91 mio.
EBIT %
-1.764,15 %
P/E
-
Udbytteafkast, %
-
Finanskalender
7.5
2025
Delårsrapport Q1'25
14.5
2025
Generalforsamling '25
20.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Spago Nanomedical article on SPAGOPIX-01 clinical results accepted for publication in Investigative Radiology
BioStock: Spago's CEO: "We want to expand cancer treatment with effective radiopharmaceuticals"
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools